Dr Michelle Lavin

Affiliations: Trinity College Dublin, St James's Hospital

Research Interests:

• Heavy Menstrual Bleeding
• Bleeding Disorders
• Access to Diagnosis
• Iron Deficiency

Dr. Michelle Lavin is a Consultant Haematologist in the National Coagulation Centre, St. James’s Hospital, Dublin, Ireland. Her research is based in the Trinity Centre for Reproductive Sciences and Women’s Health, Trinity College Dublin, where she serves as Co-Director. Her doctoral work focused on von Willebrand Disease (VWD) and phenotypic variability, particularly in the setting of low von Willebrand Factor (VWF) levels. Her current research programme centres on improving recognition and diagnosis of heavy menstrual bleeding and enhancing care for Women and Girls+ with Bleeding Disorders (WGBD+).

Dr. Lavin serves as the Chair of the World Federation of Hemophilia (WFH) VWD Committee, the European Association for Haemophilia and Allied Disorders (EAHAD) WGBD+ Working Group and as an Associate Member of the FIGO (International Federation of Gynecology and Obstetrics) Menstrual Disorders and Related Health Impacts Committee. She previously served as a Co-Chair on the ISTH VWF Scientific Subcommittee and as an invited expert on the 2021 ASH/ISTH/NHF/WFH Management of VWD guidelines & the 2021 EAHAD Principles of Care for WGBD. She has been the recipient of the Highlights of ISTH award, the Eberhard F. Mammen Young Investigator Award and, most recently, the Irish Haemophilia Society Lifetime Achievement Award for Services to Haemophilia.

Publications: